MolNFT v1 · #183314 · protein
S. cerevisiae TY1 P22 restriction factor, gag ca-ctd, AUG2 variant A273V mutant
7NLG · TY1 gag P22: “S. cerevisiae TY1 P22 restriction factor, gag ca-ctd, AUG2 variant A273V mutant”. X-ray diffraction, 2 pockets (best druggability 0.42). MolNFT v1 #183314 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7NLG
- Type
- protein
- Length
- 270 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- TY1 gag P22
- UniProt
- P08405
- Pockets
- 2 · best druggability 0.42
Structure
x-ray diffraction · 1 distinct chain · 62% helix, 3% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B, C | TY1 gag P22 | protein | 90 | 62% helix, 3% strand | P08405 |
Pockets
2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 66 | 0.42 | 0.81 | 13 | empty |
| 2 | 70 | 0.41 | 0.80 | 13 | empty |
Interfaces
2 interfaces between chains.
- A–B · 811 Ų buried · 6 hydrogen bonds · protein-protein
- A–C · 773 Ų buried · 6 hydrogen bonds · protein-protein
Compared structures
- 7NLG · S. cerevisiae Ty1 p22 restriction factor, Gag CA-CTD, AUG2 variant A273V mutant · the same entry in another collection · chain B against B, TM-score 1.00
- P08405 · AlphaFold monomer V2.0 prediction for transposon TYH3 gag polyprotein (P08405) · a predicted model of the same protein · chain A against A, TM-score 0.95
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P08405
- Elsewhere: RCSB PDB 7NLG · PDBe 7NLG · UniProt P08405
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.